Clinical Data

Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter. 

clinical-data-module-image2.png
Clinical Data – PD •

Remote Patient Management technology enhances the experience of Automated Peritoneal Dialysis

The flexibility that Peritoneal Dialysis (PD) offers renal patients allows them to maintain their lifestyle and independence. When Automated PD is combined with Remote Patient Monitoring, the flexibility is further enhanced and is associated with the potential to improve clinical outcomes and adherence.

Read More

A Focus on Clinical Research

HDx

Effects of a medium cut-off dialyzer on inflammation and cardiac and vascular function in hemodialysis patients with heart failure.

View resource
HDx

Removal Of Large-Middle Molecules, Inhibition Of Neutrophil Activation And Modulation Of Inflammation-Related Endothelial Dysfunction In Chronic Uremic Patients Treated By Expanded Hemodialysis (Hdx)

View resource
HDx

Survival of expanded hemodialysis and high-flux hemodialysis patients in Colombia: a cohort's study.

View resource
HDx

Albumin, inflammation and nutrition in hemodialisis patients in Colombia: a cohort study.

View resource
HDx

Assessment of safety and efficacy of expanded hemodialysis in comparison to HDF

View resource
HDx

Combination of medium cut-off dialyzer membrane and diet modification to reduce serum concentrations of p-cresyl sulfate and indoxyl sulfate.

View resource
HDx

Comparing advanced glycation end products removal in super high-flux hemodialysis versus high-volume hemodiafiltration: a randomized, crossover study.

View resource
HDx

Comparison of Utilities Consumption Between Different Modalities of In-Center Haemodialysis

View resource
HDx

Genetic variability in rosuvastatin metabolism explains rhabdomyolysis and consequent acute renal failure.

View resource
HDx

Heart rate-adjusted augmentation index reduces after switching low-flux dialyzers to medium cut-off dialyzers in maintenance hemodialysis patients.

View resource
HDx

LEVIL evaluates the impact of HDx on HR-QoL and symptoms, including durability-of-effect and variability.

View resource
HDx

Low-T3 syndrome: endemic in hemodialysis patients?.

View resource